Matches in SemOpenAlex for { <https://semopenalex.org/work/W2807315810> ?p ?o ?g. }
- W2807315810 endingPage "49" @default.
- W2807315810 startingPage "40" @default.
- W2807315810 abstract "Osteoporosis is a serious health problem worldwide. Semaphorins (Sema) have been described as key molecules involved in the cross-talk between bone cells (osteoblasts/osteoclasts). In this study, we investigated whether plasmid containing Sema3a could ameliorate bone loss in an ovariectomized (OVX) mouse model via (AspSerSer)6, a selectively bone-targeting moiety. Plasmid pcDNA3.1(+)-Sema3a-GFP was fabricated and transfected cells with the plasmid demonstrated statistically higher levels of Sema3A in vitro (p < 0.001). Mice were ovariectomized and injected twice weekly with (AspSerSer)6-(STR-R8)+pcDNA3.1(+)-Sema3a-GFP for four weeks. The aim of the study was twofold: firstly to design an effective bone-targeting drug-delivery system (AspSerSer)6. Secondly, the effects of Sem3A gene therapy on bone loss was investigated. Here, the targeting selectivity of pcDNA3.1(+)-Sema3a-GFP via (AspSerSer)6 to the trabecular bone surface was firstly verified by histological observation of frozen sections and immunofluorescence staining. Then, bone microstructure analysis by Micro-CT indicated significantly less bone loss in mice treated with (AspSerSer)6-(STR-R8)+pcDNA3.1(+)-Sema3a-GFP compared to the control group (p < 0.05). Furthermore,H&E staining and Safranin O staining of the decalcified sections demonstrated statistically significantly higher bone area/total area in the mice that were injected with (AspSerSer)6-(STR-R8)+pcDNA3.1(+)-Sema3a-GFP (p < 0.001, p < 0.01,respectively). TRAP staining and immunohistochemistry staining of COL I demonstrated lower numbers of osteoclasts and significantly increased numbers of osteoblasts in the bone-targeting moiety delivering pcDNA3.1(+)-Sema3a-GFP group, when compared to the control group (p < 0.01, p < 0.001,respectively). Together, our findings have identified that, (AspSerSer)6, a bone-targeting drug-delivery system based on semaphorin3A gene therapy, ameliorated bone loss in osteoporotic ovariectomized mice, by suppressing osteoclastic bone resorption and simultaneously increasing osteoblastic bone formation. Gene therapy by local site-specific Sema3A overexpression might be a potential new strategy for treating osteoporosis and bone defects." @default.
- W2807315810 created "2018-06-13" @default.
- W2807315810 creator A5051037094 @default.
- W2807315810 creator A5052595619 @default.
- W2807315810 creator A5087712756 @default.
- W2807315810 creator A5087744772 @default.
- W2807315810 date "2018-09-01" @default.
- W2807315810 modified "2023-10-15" @default.
- W2807315810 title "A bone-targeting drug-delivery system based on Semaphorin 3A gene therapy ameliorates bone loss in osteoporotic ovariectomized mice" @default.
- W2807315810 cites W1550905080 @default.
- W2807315810 cites W1790927147 @default.
- W2807315810 cites W1965154023 @default.
- W2807315810 cites W1975081085 @default.
- W2807315810 cites W1976265795 @default.
- W2807315810 cites W1977900423 @default.
- W2807315810 cites W1998464768 @default.
- W2807315810 cites W2001723304 @default.
- W2807315810 cites W2004448849 @default.
- W2807315810 cites W2009987556 @default.
- W2807315810 cites W2017686947 @default.
- W2807315810 cites W2032224123 @default.
- W2807315810 cites W2036439550 @default.
- W2807315810 cites W2041830938 @default.
- W2807315810 cites W2043007466 @default.
- W2807315810 cites W2052961418 @default.
- W2807315810 cites W2053468334 @default.
- W2807315810 cites W2063185156 @default.
- W2807315810 cites W2064628919 @default.
- W2807315810 cites W2083185600 @default.
- W2807315810 cites W2084103516 @default.
- W2807315810 cites W2084223329 @default.
- W2807315810 cites W2084694220 @default.
- W2807315810 cites W2104524606 @default.
- W2807315810 cites W2107482635 @default.
- W2807315810 cites W2115047691 @default.
- W2807315810 cites W2123346255 @default.
- W2807315810 cites W2157222066 @default.
- W2807315810 cites W2158773351 @default.
- W2807315810 cites W2162236787 @default.
- W2807315810 cites W2170373155 @default.
- W2807315810 cites W2207689886 @default.
- W2807315810 cites W2345797855 @default.
- W2807315810 cites W2521381525 @default.
- W2807315810 cites W2521508926 @default.
- W2807315810 cites W2533066994 @default.
- W2807315810 cites W2547163394 @default.
- W2807315810 cites W2580107268 @default.
- W2807315810 cites W2596231407 @default.
- W2807315810 cites W2609341771 @default.
- W2807315810 cites W2767834969 @default.
- W2807315810 doi "https://doi.org/10.1016/j.bone.2018.06.003" @default.
- W2807315810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29883786" @default.
- W2807315810 hasPublicationYear "2018" @default.
- W2807315810 type Work @default.
- W2807315810 sameAs 2807315810 @default.
- W2807315810 citedByCount "21" @default.
- W2807315810 countsByYear W28073158102019 @default.
- W2807315810 countsByYear W28073158102020 @default.
- W2807315810 countsByYear W28073158102021 @default.
- W2807315810 countsByYear W28073158102022 @default.
- W2807315810 countsByYear W28073158102023 @default.
- W2807315810 crossrefType "journal-article" @default.
- W2807315810 hasAuthorship W2807315810A5051037094 @default.
- W2807315810 hasAuthorship W2807315810A5052595619 @default.
- W2807315810 hasAuthorship W2807315810A5087712756 @default.
- W2807315810 hasAuthorship W2807315810A5087744772 @default.
- W2807315810 hasConcept C104317684 @default.
- W2807315810 hasConcept C126322002 @default.
- W2807315810 hasConcept C132538176 @default.
- W2807315810 hasConcept C134018914 @default.
- W2807315810 hasConcept C135983454 @default.
- W2807315810 hasConcept C142724271 @default.
- W2807315810 hasConcept C150903083 @default.
- W2807315810 hasConcept C153911025 @default.
- W2807315810 hasConcept C170493617 @default.
- W2807315810 hasConcept C185592680 @default.
- W2807315810 hasConcept C202751555 @default.
- W2807315810 hasConcept C207001950 @default.
- W2807315810 hasConcept C2776033226 @default.
- W2807315810 hasConcept C2776805952 @default.
- W2807315810 hasConcept C2777164284 @default.
- W2807315810 hasConcept C2778260815 @default.
- W2807315810 hasConcept C54009773 @default.
- W2807315810 hasConcept C55493867 @default.
- W2807315810 hasConcept C71924100 @default.
- W2807315810 hasConcept C74864618 @default.
- W2807315810 hasConcept C8264082 @default.
- W2807315810 hasConcept C86803240 @default.
- W2807315810 hasConceptScore W2807315810C104317684 @default.
- W2807315810 hasConceptScore W2807315810C126322002 @default.
- W2807315810 hasConceptScore W2807315810C132538176 @default.
- W2807315810 hasConceptScore W2807315810C134018914 @default.
- W2807315810 hasConceptScore W2807315810C135983454 @default.
- W2807315810 hasConceptScore W2807315810C142724271 @default.
- W2807315810 hasConceptScore W2807315810C150903083 @default.
- W2807315810 hasConceptScore W2807315810C153911025 @default.
- W2807315810 hasConceptScore W2807315810C170493617 @default.
- W2807315810 hasConceptScore W2807315810C185592680 @default.